Skip to content
PIL Logo

Betaferon

Last Updated on eMC 18-Dec-2015 View document  | Bayer plc Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18-Dec-2015 and displayed until Current

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 26-Oct-2015 and displayed until 18-Dec-2015

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 05-Sep-2014 and displayed until 26-Oct-2015

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Change to section 2 - what you need to know - warnings and precautions

Updated on 29-May-2014 and displayed until 05-Sep-2014

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 14-Jun-2012 and displayed until 29-May-2014

Reasons for adding or updating:

  • Updates to formatting
  • Change to Further Information section
  • Change to date of revision

Updated on 26-Sep-2011 and displayed until 14-Jun-2012

Reasons for adding or updating:

  • Change to date of revision
  • Change of licence holder

Updated on 03-Feb-2011 and displayed until 26-Sep-2011

Reasons for adding or updating:

  • Change to date of revision

Updated on 20-Jan-2011 and displayed until 03-Feb-2011

Reasons for adding or updating:

  • Change to Further Information section
  • Change to date of revision
  • Introduction of new pack/pack size

Updated on 17-Feb-2010 and displayed until 20-Jan-2011

Reasons for adding or updating:

  • Change to Further Information section
  • Change to date of revision

Updated on 27-May-2009 and displayed until 17-Feb-2010

Reasons for adding or updating:

  • Change to date of revision
  • Correction of spelling/typing errors
  • Introduction of new pack/pack size

Updated on 24-Dec-2008 and displayed until 27-May-2009

Reasons for adding or updating:

  • Change to Further Information section
  • Change to date of revision
  • Introduction of new pack/pack size

Updated on 16-Jul-2008 and displayed until 24-Dec-2008

Reasons for adding or updating:

  • Transfer to upgraded management system

Updated on 14-Feb-2008 and displayed until 16-Jul-2008

Reasons for adding or updating:

  • Improved Electronic Presentation
  • Change to Further Information section
  • Change to date of revision

Updated on 08-Jun-2007 and displayed until 14-Feb-2008

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 25-May-2007 and displayed until 08-Jun-2007

Reasons for adding or updating:

  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Changes to therapeutic indications

Updated on 06-Mar-2007 and displayed until 25-May-2007

Reasons for adding or updating:

  • Change to packaging
  • Change to how to administer the medicine
  • Introduction of new pack
  • Change to date of revision

Updated on 20-Jul-2006 and displayed until 06-Mar-2007

Reasons for adding or updating:

  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to date of revision

Updated on 10-Mar-2006 and displayed until 20-Jul-2006

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision

Updated on 26-Aug-2004 and displayed until 10-Mar-2006

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 02-Aug-2004 and displayed until 26-Aug-2004

Reasons for adding or updating:

  • Change to storage instructions
  • Change to date of revision

Updated on 11-Dec-2002 and displayed until 02-Aug-2004

Reasons for adding or updating:

  • Update to PIL

Updated on 05-Feb-2002 and displayed until 11-Dec-2002

Reasons for adding or updating:

  • Update to PIL

Updated on 06-Jul-2000 and displayed until 05-Feb-2002

Reasons for adding or updating:

  • No reasons supplied

Company contact details

Company image
Address

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA

Fax

+44 (0)1635 563 393

Telephone

+44 (0)1635 563 000

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

interferon beta-1b

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue